# Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects

> **NCT03453060** · PHASE1 · COMPLETED · sponsor: **Aronora, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** E-WE Thrombin- Dose 1
- **DRUG:** E-WE Thrombin- Dose 2
- **DRUG:** E-WE Thrombin- Dose 3
- **DRUG:** E-WE Thrombin- Dose 4
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03453060
- **Lead sponsor:** Aronora, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2018-11-25
- **Final completion:** 2018-11-25
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453060, "Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03453060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*